Position in AMGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$596,773
+$31,702 QoQ
Shares Held
1,648
+2.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#2,056
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bedel Financial Consulting, Inc. holds $404,013,991 across 11 Drug Manufacturers - General names. AMGN ranks #7 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
328,198 | $393,650,559 | |
| 2 | JNJ |
Johnson & Johnson
|
13,084 | $3,322,943 | |
| 3 | ABBV |
AbbVie Inc.
|
11,757 | $2,958,531 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,015 | $901,427 | |
| 5 | PFE |
Pfizer Inc
|
31,588 | $760,639 | |
| 6 | NVS |
Novartis AG
|
4,326 | $677,970 | |
| 7 | AMGN |
Amgen Inc
This page
|
1,648 | $596,773 | |
| 8 | GSK |
GSK plc
|
7,562 | $396,400 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $596,773 | 1,648 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $565,071 | 1,606 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $525,659 | 1,606 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $453,213 | 1,606 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $443,664 | 1,589 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $495,052 | 1,589 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $395,390 | 1,517 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $467,526 | 1,451 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $455,239 | 1,457 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $411,411 | 1,447 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $418,205 | 1,452 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $388,895 | 1,447 | Shares | Sole | 2024-02-08 | |
| 2023-06-30 | $321,262 | 1,447 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $349,812 | 1,447 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $380,040 | 1,447 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $338,776 | 1,503 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $365,679 | 1,503 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $363,455 | 1,503 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $338,129 | 1,503 | Shares | Other | 2022-01-11 | |
| 2021-09-30 | $319,612 | 1,503 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $366,356 | 1,503 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $311,758 | 1,253 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $265,097 | 1,153 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $293,046 | 1,153 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $274,305 | 1,163 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $243,073 | 1,199 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||